Clinical significance of V617F mutation of the JAK2 gene in patients with chronic myeloproliferative disorders.
Basquiera AL, Soria NW, Ryser R, Salguero M, Moiraghi B, Sackmann F, Sturich AG, Borello A, Berretta A, Bonafé M, Barral JM, Palazzo ED, García JJ.
Basquiera AL, et al.
Hematology. 2009 Dec;14(6):323-30. doi: 10.1179/102453309X12473408860226.
Hematology. 2009.
PMID: 19941738
Free article.